AcouSort AB (publ) (STO:ACOU)

Market Cap	103.70M +81.3%
Revenue (ttm)	10.43M +4.0%
Net Income	-12.15M
EPS	-0.64
Shares Out	21.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,801
Average Volume	39,547
Open	4.880
Previous Close	4.900
Day's Range	4.770 - 4.900
52-Week Range	2.030 - 4.950
Beta	0.11
RSI	76.51
Earnings Date	May 22, 2026

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrumen...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 16
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACOU

Financial Performance

In 2025, AcouSort AB's revenue was 10.43 million, an increase of 4.01% compared to the previous year's 10.03 million. Losses were -12.15 million, -19.40% less than in 2024.